Compare FOA & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOA | KRMD |
|---|---|---|
| Founded | 2013 | 1980 |
| Country | United States | United States |
| Employees | 784 | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.1M | 186.5M |
| IPO Year | N/A | 2019 |
| Metric | FOA | KRMD |
|---|---|---|
| Price | $19.70 | $3.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $26.00 | $6.50 |
| AVG Volume (30 Days) | 46.7K | ★ 116.3K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | $0.58 | $20.32 |
| Revenue Next Year | $6.91 | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $15.77 | $2.91 |
| 52 Week High | $29.58 | $6.61 |
| Indicator | FOA | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.96 | 45.86 |
| Support Level | $19.00 | $3.82 |
| Resistance Level | $20.17 | $4.33 |
| Average True Range (ATR) | 0.80 | 0.15 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 67.37 | 31.40 |
Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.